1. Home
  2. CDNA vs GBDC Comparison

CDNA vs GBDC Comparison

Compare CDNA & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$84.86

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Logo Golub Capital BDC Inc.

GBDC

Golub Capital BDC Inc.

N/A

Current Price

$12.70

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
GBDC
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
2007
2009

Fundamental Metrics

Financial Performance
Metric
CDNA
GBDC
Price
$84.86
$12.70
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
★ $65.33
$13.63
AVG Volume (30 Days)
1.3M
★ 1.3M
Earning Date
10-29-2026
11-17-2026
Dividend Yield
N/A
★ 10.33%
EPS Growth
N/A
★ 4.41
EPS
★ 2.45
0.29
Revenue
★ $48,324,000.00
N/A
Revenue This Year
$30.36
N/A
Revenue Next Year
$6.23
N/A
P/E Ratio
★ $33.32
$43.91
Revenue Growth
★ 18.93
N/A
52 Week Low
$14.27
$11.77
52 Week High
$73.43
$14.41

Technical Indicators

Market Signals
Indicator
CDNA
GBDC
Relative Strength Index (RSI) 79.73 61.10
Support Level $17.30 $12.70
Resistance Level N/A $12.97
Average True Range (ATR) 4.65 0.21
MACD 0.83 0.09
Stochastic Oscillator 80.27 88.21

Price Performance

Historical Comparison
CDNA
GBDC

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About GBDC Golub Capital BDC Inc.

Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.

Share on Social Networks: